41625 Tapinarof Cream 1% Once Daily (QD) for Plaque Psoriasis: Post Hoc Analysis of Physician Global Assessment x Body Surface Area (PGAxBSA) Composite for the PSOARING 1 and 2 Trials
Strober B, Kircik L, Green L, Lockshin B, Brown P, Tallman A. 41625 Tapinarof Cream 1% Once Daily (QD) for Plaque Psoriasis: Post Hoc Analysis of Physician Global Assessment x Body Surface Area (PGAxBSA) Composite for the PSOARING 1 and 2 Trials. Journal Of The American Academy Of Dermatology 2023, 89: ab92. DOI: 10.1016/j.jaad.2023.07.371.Peer-Reviewed Original Research